Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 20Terminated 11Active not recruiting 5Recruiting 4Unknown 3Withdrawn 2

Sponsor Class

INDUSTRY 3OTHER 1NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 2Gastrointestinal 2Breast 2Thoracic 1Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Pancreatic Neoplasms 18Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Stomach Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Adenocarcinoma 2Lung Neoplasms 2Inflammatory Breast Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Solid Cancer 1Sarcoma 1Oropharyngeal Neoplasms 1Non-Small Cell Lung Cancer Metastatic 1Non Small Cell Lung Cancer NSCLC 1Neoplasms 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy 1Lip Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Laryngeal Neoplasms 1Kidney Neoplasms 1Invasive Breast Cancer 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 34Specimen Handling 18Paclitaxel 16Magnetic Resonance Spectroscopy 15Carboplatin 14Biopsy 14Nivolumab 13Ipilimumab 12Gemcitabine 10Irinotecan 9Radiosurgery 8atezolizumab 7abemaciclib 7Radiation 7Pemetrexed 7Cisplatin 7Capecitabine 7130-nm albumin-bound paclitaxel 7trastuzumab deruxtecan 6olaparib 6durvalumab 6avelumab 6Docetaxel 6osimertinib 5adagrasib 5Trastuzumab 5Fulvestrant 5Cetuximab 5Albumin-Bound Paclitaxel 5palbociclib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasm Metastasis × Albumin-Bound Paclitaxel × Clear all
NCT03678883 2026-04-03

9-ING-41 in Patients With Advanced Cancers

Actuate Therapeutics Inc.

Phase 2 Active not recruiting
350 enrolled
BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT04895358 2026-03-11

KEYNOTE-B49

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
340 enrolled
Breast

Parkinson Disease 4, Autosomal Dominant Lewy Body, Breast Neoplasms, Neoplasm Metastasis

NCT05631899 2025-11-24

CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors

Chinese PLA General Hospital

Phase 1 Active not recruiting
9 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05669482 2025-09-02

RAMP205

Verastem, Inc.

Phase 1/2 Active not recruiting
40 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT04879368 2025-07-17

INTEGRATEIIb

Australasian Gastro-Intestinal Trials Group

Phase 3 Active not recruiting
450 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡